PAI-1 mediates acquired resistance to MET-targeted therapy in non-small cell lung cancer.
Thu YM, Suzawa K, Tomida S, Ochi K, Tsudaka S, Takatsu F, Date K, Matsuda N, Iwata K, Nakata K, Shien K, Yamamoto H, Okazaki M, Sugimoto S, Toyooka S.
Thu YM, et al. Among authors: sugimoto s.
PLoS One. 2024 May 17;19(5):e0300644. doi: 10.1371/journal.pone.0300644. eCollection 2024.
PLoS One. 2024.
PMID: 38758826
Free PMC article.